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Highlights 
• The role of inhibitory functions in adult TS/CTD is unclear. 
• Adolescents and adults with TS/CTD may possess intact or superior inhibitory control. 
• We examined the association between baseline inhibitory function and treatment response in adults TS/CTD. 
• Neuropsychological tests did not predict treatment response regardless of treatment type. 
• Results support the notion that inhibitory deficits are not core facets of TS/CTD in adults. 
 
Abstract 
Tourette's disorder (TS) and chronic tic disorder (CTD) are neurodevelopmental disorders characterized by involuntary vocal 
and motor tics. Consequently, TS/CTD have been conceptualized as disorders of cognitive and motor inhibitory control. 
However, most neurocognitive studies have found comparable or superior inhibitory capacity among individuals with 
TS/CTD relative to healthy controls. These findings have led to the hypothesis that individuals with TS/CTD develop 
increased inhibitory control due to the constant need to inhibit tics. However, the role of cognitive control in TS/CTD is not 
yet understood, particularly in adults. To examine the role of inhibitory control in TS/CTD, the present study investigated 
this association by assessing the relationship between inhibitory control and treatment response in a large sample of adults 
with TS/CTD. As part of a large randomized trial comparing behavior therapy versus supportive psychotherapy for TS/CTD, a 
battery of tests, including tests of inhibitory control was administered to 122 adults with TS/CTD at baseline. We assessed 
the association between neuropsychological test performance and change in symptom severity, as well as compared the 
performance of treatment responders and non-responders as defined by the Clinical Global Impression Scale. Results 
indicated that change in symptoms, and treatment response were not associated with neuropsychological performance on 
tests of inhibitory control, intellectual ability, or motor function, regardless of type of treatment. The finding that significant 
change in symptom severity of TS/CTD patients is not associated with impairment or change in inhibitory control regardless 
of treatment type suggests that inhibitory control may not be a clinically relevant facet of these disorders in adults. 
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1. Introduction 
Tourette's disorder (TS) and persistent (chronic) motor or vocal tic disorder (CTD), are 
neurodevelopmental disorders characterized by multiple vocal and motor tics (American Psychiatric 
Association, 2013). The worldwide prevalence of tic disorders in children is estimated at 0.8%, with 
higher prevalence in boys (1.1%), whereas the prevalence of tic disorders in adults is estimated at 
1:2000 (Knight et al., 2012). Tic disorders usually onset in childhood and their severity tend to decrease 
with age. However, it has been estimated that 11% of individuals with tic disorders continue to 
experience moderate to severe tics resulting in daily life functional impairments into adulthood (Bloch 
et al., 2006, Leckman et al., 1998). 
Compared to controls, individuals diagnosed with tic disorders exhibit different patterns of brain 
activity in the cortico-striato-thalamo-cortical (CSTC) neural circuitry (Leckman et al., 2010). The 
prominent role of the CSTC system in executive and inhibitory functions, together with the clinical 
presentation of tics, led to the hypothesis that tic disorders are disorders of motor disinhibition, 
wherein patients experience difficulties suppressing tics (Jung et al., 2013). Indeed, imaging studies 
reveal increased activation of the CSTC network in patients with tic disorders during attempts to inhibit 
eye blinking (Mazzone et al., 2010). 
1.1. Inhibitory control in tic disorders 
Studies investigating executive function in tic disorders, particularly tasks of inhibitory control 
(including response inhibition, response suppression, and interference control), reveal mixed results 
(Kalsi et al., 2015). In fact, the majority of studies utilizing the gold standard tests of inhibitory control 
have revealed intact performance among adults with tic disorders. These include research utilizing 
Go/No-Go tasks (GNG; Serrien et al., 2005, Thomalla et al., 2014, Watkins et al., 2005) and the Stroop 
task (Eddy and Cavanna, 2014, Thibault et al., 2009). Very few studies found underperformance on 
tasks of behavioral inhibition in adults with TS/CTD (Jackson et al., 2015), but these results were found 
on tasks such as Sentence Completion, or the Simon task (Dursun et al., 2000, Georgiou et al., 1995). In 
addition, it has been argued that such studies tend to include participants with comorbid disorders 
such as Attention Deficit/Hyperactivity Disorder (ADHD) and OCD, and that inhibitory deficits may be 
found mainly in individuals diagnosed with tic disorders concomitant with OCD and/or ADHD (Jung et 
al., 2013). Notably, recent reviews of the literature highlight findings indicating a paradoxical superior 
behavioral control among adolescents and adults diagnosed with tic disorders compared to controls—
hypothetically due to years of experience attempting to inhibit tics (Jackson et al., 2015, Jung et al., 
2013). However, more research is required to support this notion, and the role of behavioral inhibition 
in adult TS/CTD remains unclear. 
1.2. Neuropsychological functions and treatment response in tic disorders 
Behavioral interventions for tic disorders, such as Habit Reversal Therapy (HRT) and its newer version 
called Comprehensive Behavioral Intervention for Tics (CBIT), are found to be effective for the 
treatment of tic disorders, (Piacentini et al., 2010, Wilhelm et al., 2012) yielding large effect sizes in 
adult samples (McGuire et al., 2014). However, very little is known about predictors of treatment 
response to behavior therapy for tic disorders. Neuropsychological predictors of treatment response 
may be important in informing treatment selection, as well as informing treatment development. To 
our knowledge, there are only three studies that examined changes in cognitive function following 
cognitive behavioral therapy (CBT) for adult TS/CTD. Lavoie et al. (2011) reported improved 
performance on the Purdue Pegboard Test following treatment. However, this test assesses basic 
motor functions, and the authors did not include executive function or other neuropsychological tests 
in their study. In another study (Deckersbach et al., 2006) the authors compared a small sample of 
individuals diagnosed with TS receiving Habit Reversal Therapy (n = 15) to a sample (n = 15) receiving 
supportive psychotherapy. The authors found that aspects of performance on a visuospatial priming 
task had predictive value for treatment response. Notably, the authors used this task to assess 
response inhibition, although the task was visuospatial in nature which poses difficulties in 
differentiating between the predictive value of visuospatial function versus response inhibition. In a 
recent study, however, Morand-Beaulieu et al. (2015) employed a stimulus-response compatibility 
inhibition task in a sample of 20 TS/CTD adult patients and 20 controls and found no performance 
difference between pre- and post-treatment. Thus, the goal of this study was to utilize gold standard 
tasks of inhibitory control—namely, the Go/No-Go (GNG) test assessing response inhibition, and the 
Stroop test, assessing interference control—to predict treatment response to CBIT among adults with 
TS and CTD. In light of the mixed literature and the novelty of this study, our investigation is 
exploratory. 
2. Materials and methods 
2.1. Study design 
Participants were recruited as part of a large-scale, randomized controlled trial comparing 10 weeks (8 
sessions) of Comprehensive Behavioral Intervention for Tics (CBIT) to psychoeducation and supportive 
therapy (PST). See Wilhelm et al. (2012) for a detailed description of the study procedures. 
Neuropsychological measures were administered at baseline. Clinical severity was assessed by an 
independent evaluator (a clinician blind to treatment condition) at baseline and at post-treatment. 
Participants were recruited at three sites: Massachusetts General Hospital/Harvard Medical School, 
Yale University, and University of Texas Health Science Center at San Antonio. 
2.2. Participants 
Adult participants (n = 122) were included in the present study. Inclusion criteria were age ≥ 16 years, a 
diagnosis of TS or CTD of moderate severity or greater based on the Clinical Global Impression-Severity 
Score (CGI-S ≥ 4), and a Yale Global Tic Severity Scale (YGTSS; Leckman et al., 1989) total score ≥ 14 
(> 10 for those with only motor or vocal tics). Additional inclusion criteria were fluency in English, 
IQ > 80 on a standardized intelligence test, no history of schizophrenia or pervasive developmental 
disorder, and no current substance use disorder. Other comorbidities (bipolar disorder, depression, 
anxiety and related disorders, and ADHD) were permitted provided that the co-occurring disorder was 
stable and not of sufficient severity to require clinical attention. Participants were excluded if they 
previously completed a course (> 4 sessions) of CBT for tics. Medications for tics were permitted 
provided the dose was stable for at least 6 weeks with no planned changes for the duration of the 
study. Fifty-one participants (41.8%) were medicated—out of which 8 participants were on tic 
medication only (e.g., alpha agonists, neuroleptics), 23 were on other medications in addition to tic 
medication, and 20 participants were on non-tic medication only (e.g., SSRIs). 
2.3. Treatments 
A comprehensive description of the study treatments can be found elsewhere (Wilhelm et al., 2012). 
Briefly, both treatments consisted of eight 60–90 min sessions administered over 10 weeks. CBIT 
comprised psychoeducation, tic awareness training, competing response training, relaxation training, 
and functional analysis. PST comprised disorder-specific psychoeducation and supportive therapy. 
Therapists had at least a master's degree in clinical psychology, followed detailed treatment manuals, 
and were specifically trained on both treatments for this study. Treatment sessions were videotaped 
and randomly selected for fidelity ratings. Fidelity was good or better for 75.7% of CBIT tapes and 
87.7% of PST tapes. 
2.4. Measures 
2.4.1. Clinical measures 
Structured Clinical Interview for DSM-IV Patient Version (SCID-P): 
Diagnostic status was assessed via the SCID-P (First et al., 2002), a widely-used and well-validated semi-
structured interview developed to establish past and current DSM-IV diagnoses. 
Clinical Global Impression-Improvement Scale (CGI-I): 
The CGI-I (Guy and Bonato, 1970) is a single-item standard global assessment used to assess changes in 
severity of the target disorder. The CGI-I scores range between 1 (very much improved) and 7 (very 
much worse). Positive response to treatment in the present study was defined as a score of 2 or 1 
(much improved, or very much improved). The CGI-I score in each time point was assessed by an 
evaluator that was blind to treatment assignment. 
Yale Global Tic Severity Scale (YGTSS): 
The YGTSS (Leckman et al., 1989) is a clinician-rated scale used to assess tic severity and was the 
primary clinical outcome measure in this study. Motor and phonic tics are rated separately from 0 to 5 
on several scales including: number, frequency, intensity, complexity, and interference. Thus, motor 
and phonic tic scores can range from 0 to 25; the combined Total Tic score ranges from 0 to 50. There 
is also an impairment score that rates the overall burden due to tics. The impairment scale yields a 
single score from 0 to 50 with higher scores indicating higher levels of overall impairment associated 
with tics. The YGTSS has demonstrated strong psychometric properties with good internal consistency, 
excellent inter-rater reliability, and strong convergent and divergent validity (Leckman et al., 1989). 
The primary outcome measure in this study was the Total Tic score, as it shows the greatest sensitivity 
to change in tic severity over brief periods of time (Lin et al., 2002). 
2.4.2. Neuropsychological tests 
2.4.2.1. General tests 
Wechsler Test of Adult Reading (WTAR): 
The Wechsler Test of Adult Reading (WTAR; Wechsler, 2001) provides an estimate of premorbid IQ. 
The WTAR shows a strong (r > 0.7) correlation with IQ as assessed by the Wechsler Adult Intelligence 
Scale (Strauss et al., 2006). Subjects are to read a list of words and receive a point for each correctly 
pronounced word. 
Purdue Pegboard Test: 
The Purdue Pegboard Test (Tiffin and Asher, 1948) measures manual dexterity. The task consists of a 
board with holes and a set of pegs. Subjects are instructed to place the pegs in the holes (one at a 
time) as quickly and correctly as possible. Outcomes can be presented separately for left, right, and 
both hands. For the purposes of the present paper, we report only the results for both hands. Tiffin 
and Asher (1948) provide a means to calculate scaled scores; however, the normative samples are 
comprised of adults who applied for factory and production jobs and therefore may not be 
representative of the general population. We therefore use raw scores in analyses and present 
descriptive data from a large general sample of Canadian adults (Yeudall et al., 1986) for comparison. 
2.4.2.2. Inhibitory control tasks 
Stroop color & word test: 
The Stroop task is a classic cognitive interference task (Stroop, 1935). It assesses inhibition of a 
dominant response (reading) in favor of an alternative competing response (color naming). In the first 
condition, participants are presented with color words (written in black) and are asked to name the 
color as quickly as possible. In the second condition, subjects are asked to name the color of a 
nonsense stimulus (XXXXX) as quickly as possible. In the Interference condition, participants are 
presented with color words (e.g. red) written in a color that is inconsistent with the word's meaning 
(e.g. red written in blue). Participants are required to name the color the word is printed in as quickly 
as possible. An interference (color-word) score was calculated as a standardized score based on age 
and education-corrected normative data. 
Go/No-Go task (GNG): 
The GNG task (Serrien et al., 2005) is a computerized measure of motor response inhibition. In the 
task, participants view a cue stimulus (an arrow pointing to the right or left) that signaled them to get 
ready, followed by a target stimulus (the figure 0 or the letter S) that indicated the correct response. 
Participants were seated in front of a desk with a custom-built button-press device held in each hand 
and faced a computer screen at a distance of 80 cm. A fixation cross was visible continuously in the 
center of the screen. During each trial, an arrow was presented that pointed to the right or to the left 
and served as a cue for a following target. On “go” trials (75% of trials), the target stimulus was the 
figure 0. On “No-Go” (response inhibition) trials (25% of trials), the target signal was the letter S, and 
indicated that the planned response needed to be withheld (inhibited). 
The cue and target stimuli appeared on the right or left side of the fixation cross to enhance stimulus-
response compatibility and remained visible on the screen for 500 ms; a fixed time interval of 3 s 
occurred between the onsets of cue and target. Participants responded to the target signal by pressing 
the right-sided or left-sided button as fast as possible with the thumb of the right or left hand (as 
instructed by the direction of the cue arrow and the asymmetry of the target signal with respect to the 
central fixation cross on screen). Commission errors were calculated as the percent of false alarms 
(incorrect positive responses) divided by the total number of No-Go trials (20 trials). Omission errors 
were calculated as the percent of misses (incorrect negative responses) divided by the total number of 
go trials (60 trials). 
2.5. Statistical analyses 
Clinical improvement was computed as the change in YGTSS total score from baseline to post-
treatment (week 10). Each neuropsychological measure was examined in a separate regression model 
as a predictor of treatment outcome with treatment condition (CBIT vs. PST) included as a moderator. 
These analyses were conducted using the PROCESS macro for SPSS (Hayes, 2013). Multivariate analysis 
of variance was conducted in order to assess performance differences between treatment responders 
and non-responders on neuropsychological tasks. 
3. Results 
Participants were 122 adults (M age = 31.55, SD = 13.72; 36% female) with an average total tic severity 
of 22.91 (SD = 6.60) as assessed by the YGTSS. Participants were generally of average intelligence 
(WTAR FSIQ M = 106.02, SD = 9.56). Motor functioning was somewhat deficient: The average Purdue 
Pegboard performance for both hands was approximately one standard deviation below the mean 
reported in a large normative adult sample (M = 11.32, SD = 2.02 in this sample, versus norms 
M = 12.69, SD = 1.55; Yeudall et al., 1986), and was equivalent to scores obtained in other adult CTD 
and TS samples (e.g., Lavoie et al., 2007) (Table 1). 
Table 1. General neuropsychological functioning as a predictor of treatment response. 
  
B SE (B) t p 95% CI R-sq F 
WTAR FSIQ 
      
0.18 6.95***  
Condition 12.66 12.10 1.05 0.30 − 11.34–36.67 
  
 
WTAR FSIQ − 0.09 0.07 − 1.18 0.24 − 0.24–0.06 
  
 
Condition x FSIQ − 0.08 0.11 − 0.73 0.47 − 0.31–0.14 
  
Purdue Pegboard Test 
      
0.17 6.54***  
Condition 9.66 5.72 1.68 0.09 − 1.69–21.01 
  
  
B SE (B) t p 95% CI R-sq F  
Both hands − 0.17 0.34 − 0.50 0.62 − 0.85–0.51 
  
 
Condition x both hands interaction − 0.50 0.50 − 1.01 0.32 − 1.48–0.49 
  
WTAR = Wechsler Test of Adult Reading. FSIQ = Full Scale IQ. WTAR analysis n = 102. Purdue analysis n = 103. 
***p < 0.001. 
 
3.1. Neuropsychological predictors of treatment response 
3.1.1. General measures 
No significant association was found between neuropsychological test performance and change in 
symptoms (i.e., pre – post total YGTSS score) for any of the tests administered, nor did performance 
interact with treatment condition to predict improvement. FSIQ did not significantly predict change in 
symptoms (B = − 0.09, p = 0.24), nor did FSIQ interact with treatment condition to predict change 
(B = − 0.08, p = 0.47). Purdue Pegboard Task performance similarly failed to predict change in 
symptoms (B = − 0.17, p = 0.62), nor did performance interact with treatment condition (B = − 0.50, 
p = 0.32) (Table 2). No significant differences were found on these two tasks between treatment 
responders and non-responders, and no significant interaction effect was found between the two 
treatment conditions (Table 3). Medication status added to the regression and MANOVA models did 
not alter results. 
Table 2. Inhibition as a predictor of treatment outcome. 
  
B SE (B) t p 95% CI R2 F 
Stroop task 
 Stroop word score 
      
0.14 5.38***  
Condition 2.53 3.90 0.65 0.52 − 5.21–10.28 
  
 
Word t-score − 0.06 0.06 − 1.03 0.31 − 0.18–0.06 
  
 
Condition x word t-score 0.03 0.08 0.33 0.74 − 0.13–0.19 
  
 Stroop color score 
      
0.15 5.83***  
Condition 4.09 4.36 0.94 0.35 − 4.55–12.74 
  
 
Color t-score − 0.07 0.07 − 1.06 0.29 − 0.21–0.06 
  
 
Condition x color t-score − 0.01 0.09 − 0.07 0.95 − 0.19–0.18 
  
 Stroop interference 
      
0.14 5.52***  
Condition 8.88 6.47 1.37 0.17 − 3.95–21.72 
  
 
Interference t-score − 0.02 0.09 − 0.18 0.86 − 0.19–0.16 
  
 
Condition x interference − 0.10 0.12 − 0.78 0.44 − 0.34–0.15 
  
 
Go/NoGo task 
 Commission errors 
      
0.14 5.07***  
Condition 4.20 1.29 3.27*** 0.00 1.65–6.75 
  
 
Commission errors 0.01 0.04 0.19 0.85 − 0.07–0.09 
  
 
Condition x commission errors − 0.02 0.06 − 0.30 0.76 − 0.14–0.11 
  
  
B SE (B) t p 95% CI R2 F 
 Omission errors 
      
0.14 5.11***  
Condition 4.08 1.10 3.71*** 0.00 1.90–6.26 
  
 
Omission errors 0.02 0.05 0.45 0.66 − 0.08–0.12 
  
 
Condition x omission errors − 0.03 0.10 − 0.26 0.79 − 0.21–0.16 
  
Stroop analyses n = 104. Go/NoGo analyses n = 100. 
***p < 0.001. 
Table 3. Neuropsychological test performance as a function of treatment response and treatment type. 
 
Responders Non-responders Group comparison Interaction Tx type  
M SD M SD F η2 F 
WTAR FSIQ 106.04 8.85 107.5 9.13 0.44 0.01 0.12 
Purdue Pegboard 11.00 2.08 11.61 11.61 3.89 0.05 0.75 
Stroop word T score 44.69 12.99 47.40 12.66 0.41 0.01 0.42 
Stroop color T score 43.81 11.53 46.74 10.89 1.30 0.02 0.11 
Stroop interference T score 52.12 5.69 52.37 9.39 0.37 0.01 0.45 
Go/NoGo commissions (#) 2.50 2.73 2.43 3.45 0.58 0.02 1.74 
Go/NoGo omissions (#) 1.08 1.60 2.44 5.31 1.75 0.05 0.19 
WTAR = Wechsler Adult Test for Reading. FSIQ = Full Scale IQ. η2 = unadjusted Eta squared. Interaction Tx type = difference 
between responders and non-responders as a function of treatment type. # = raw number of hits. Comparison sample sizes: 
WTAR - 75, 27; Purdue – 76, 27; Stroop – 77, 27; Go/NoGo – 73, 26. 
3.1.2. Inhibitory control tasks 
Stroop interference did not predict change in symptoms (B = 0.02, p = 0.86) or interact with treatment 
condition to predict change (B = 0.10, p = 0.44). Similarly, GNG commission errors did not predict 
change in YGTSS (B = − 0.01, p = 0.85) or interact with treatment condition to predict change (B = 0.02, 
p = 0.76). GNG omission errors did not predict change in YGTSS (B = − 0.02, p = 0.66) or interact with 
treatment condition to predict change (B = 0.03, p = 0.79) (Table 2). Finally, no significant differences 
were found on inhibitory tasks between treatment responders and non-responders, and no significant 
interaction effect was found between the two treatment conditions (Table 3). Medication status added 
to the regression and MANOVA models did not alter results. 
4. Discussion 
To our knowledge, this is the first large scale study to investigate the predictive validity of 
neuropsychological tests of response inhibition on treatment response for tic disorders in adults. Our 
results show no significant association between performance on the Stroop or GNG tests and 
treatment response, regardless of the type of treatment (i.e., CBIT and PST). Moreover, no association 
was found between general intellectual ability or psychomotor functioning and treatment response. 
These null findings were evident when assessed using change in symptoms severity as a continuous 
dependent variable, as well as when assessed using the binary CGI-I criterion. Two previous studies 
examined the association between neuropsychological test performance and treatment response in 
TS/CTD samples. In contrast to our findings, Lavoie et al. (2011) reported improved performance on 
the Purdue Pegboard Test following CBT in a sample of TS patients. However, the sample size in their 
study was very small (n = 10). Similarly, Deckersbach et al. (2006) found some predictive validity of a 
visuospatial priming task for treatment response in participants with TS. However, the study had a 
small sample, and it utilized a visuospatial response inhibition task that is heavily influenced by 
visuospatial abilities that may mask inhibitory function. In contrast, our results are in accord with a 
more recent study that reported no association between treatment repsonse and performance on a 
stimulus-response compatibility inhibition task in a sample of 20 TS/CTD patients (Morand-Beaulieu et 
al., 2015). 
The unique clinical presentation of patients with tic disorders could be perceived as a control deficit, 
and one might assume that these individuals suffer from substantial cognitive deficits, particularly in 
executive function such as inhibitory control. The results of the relatively small body of research are 
inconsistent, however. In fact, the majority of studies utilizing well-validated measures of executive 
function in TS/CTD samples indicated intact performance compared to controls (e.g., Eddy and 
Cavanna, 2014, Serrien et al., 2005, Thibault et al., 2009, Thomalla et al., 2014). Indeed, recent reviews 
of inhibitory control in TS conclude that there is no convincing evidence of deficits in inhibitory control 
(or executive functions) in TS/CTD (Jackson et al., 2015, Jung et al., 2013). In light of studies exhibiting 
enhanced motor inhibition in TS/CTD, it has been suggested that “This finding is consistent with the 
proposal that the frequent need to actively suppress tics leads to a generalised enhancement in the 
efficacy of volitional control mechanisms in TS that extends to laboratory tasks of cognitive control of 
motor output.” (Jung et al., 2013, p. 1017). 
It should be noted, however, that it has been suggested that prevalent comorbid conditions such as 
ADHD act as protective factors against meaningful cognitive deficits in individuals diagnosed with TS 
(for a review see Kalsi et al., 2015). However, this notion—that has been based on a single study 
assessing pediatric samples (Sukhodolsky et al., 2010), is theoretically problematic given the strong 
association between ADHD and cognitive deficits, and due to the need for more research directly 
examining this hypothesis, particularly in adults. Although more research is needed, if executive 
functions are indeed intact among individuals diagnosed with TS/CTD, while tic severity can be 
substantial and even impairing, it would be reasonable to assume that these cognitive functions would 
be ineffective predictors of treatment response. In fact, our results of lack of an association between 
change in the core symptoms of TS/CTD and baseline response inhibition lends support to the notion 
that tics are not a direct result of failure of motor nor cognitive inhibition. It is important to note, 
however, that research into neuropsychological performance as predictors of treatment response in 
other disorders where neuropsychological deficits are more pronounced is inconsistent, and overall 
neurocognitive functions do not appear to be a promising domain in terms of predictions of treatment 
response (e.g., Braga et al., 2016, Douglas et al., 2011, Granholm et al., 2008, Moritz et al., 2005, Wild 
and Gur, 2008). 
The current study has several strengths. First, to our knowledge, this study is the largest to date to 
provide neuropsychological data on adults with TS/CTD. Second, the present sample underwent a 
rigorous screening procedure, and was provided with a disorder-specific evidence based treatment. 
Third, examination of the association between neuropsychological test performance and treatment 
response, may provide more meaningful insight compared to a cross-sectional study. Nevertheless, the 
present study is not without limitations. First, the present study did not include a non-clinical control 
sample, which hinders direct conclusions concerning an objective deficit on neuropsychological tasks. 
However, the WTAR and the Stroop tests produced scaled scores indicating performance on the 
normative range, and participants' performance on the Purdue Pegboard was found to be one 
standard deviation below the norms and similar to performance scores reported in other TS/CTD 
studies. In addition, the present study focused on specific executive function indices tapping response 
inhibition (GNG) and interference control (Stroop), and no other executive function, for which results 
may be theoretically different. 
5. Conclusion 
In the largest sample to date to assess neuropsychological predictors of treatment response in adult 
individuals diagnosed with TS/CTD, we found no association between neurocognitive functioning and 
treatment response, regardless of treatment type. These results were similar when treatment 
response was assessed as change in symptom severity, and when assessed using the definition of 
treatment response according the CGI-I. In addition, scaled scores derived from test means indirectly 
indicated that participants largely performed in the normative range. These results support recent 
research suggesting that inhibitory control deficits do not play a central role in TS/CTDs 
psychopathology. However, neuropsychological investigations in adult TS/CTD are limited, and more 
research is needed in order to provide clearer insight into neurocognitive functioning in these 
disorders. 
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